We read with great interest the Article on the EMERALD-1 trial.1 The primary endpoint of the trial was progression-free survival and, for 78 patients, death occurred before progression: 37 (27%) of ...
Open Text has agreed to divest a part of its analytics portfolio to NetDocuments for $163 million in cash. The business, known as eDOCS, is primarily focused on automating the work of legal ...